A Practical Risk Management Session with Merck
New for 2012: Learn how to effectively manage and mitigate risk in technology transfer in an interactive session with Sascha Basten, Associate Director at Merck
Global Contract Manufacturing Conference for Bio
The GPCM bio focused stream delivers more in depth discussion for those specifically working within the biopharmaceutical and biologics field
Discover Outsourcing Potential in Emerging Markets
GPCM 2012 has a whole morning dedicated to emerging markets and the challenges and opportunities they present. Watch presentations, hear case studies and pose questions to our panellists with expertise and experience in working in Eastern Europe, Latin America, Asia and more!
Global Pharmaceutical Contract Manufacturing Conference
Bringing together senior professionals working in the pharmaceutical contract manufacturing area for focused discussion and dedicated networking over 2 days
The leading annual worldwide meeting for contract manufacturing stakeholders
Decreasing profits in pharmaceuticals over the past 5 years has put manufacturing and product costs under greater scrutiny. As a result there has been an increase in the need for a reduction in the size and cost of internal manufacturing and sourcing of cheaper products from external parties. Contract Manufacturing in pharmaceuticals continues to increase, and Pharma IQ would like to present its 5th Global Pharmaceutical Contract Manufacturing Conference, once again the leading event for contract manufacturing specialist across the globe.
This year Pharma IQ will deliver another packed agenda, providing a platform for open discussion between contract sponsors and supplier. This is a unique opportunity to spend 2 days ironing out reoccurring issues and setting the foundations for a working partnership.
To facilitate the best discussion and maximise the value for all involved, GPCM 2012 has more interactivity than ever with panel discussions, round tables, risk management sessions and workshops.
Key topics to be discussed at this year's event:
- Analyse the current dynamics of the contract manufacturing landscape across pharma and bio as we move towards an external supply model
- How to effectively source new partners and ensure expectations from each side of the partnership are meet from outset
- Effective risk management strategies to minimise risk in the sourcing, selection and management aspects of the contract manufacturing process
- Hear a CMO Perspective- what are they actually looking for in their pharma partners?
- How to ensure you have all the necessary information for a smooth and effective tech transfer
- What can we learn from the lessons of small, virtual pharma?
- Opportunities and challenges of emerging markets
2012 sees the return of GPCM’s Bio Stream!
- As outsourcing increases in pharmaceuticals, we can see the same happening in biopharmaceuticals. Our recent survey showed that 58% of bio companies questioned now outsource more than 50% of their API.
- GPCM 2012 will address this key industry trend with presentations, case studies and interactive sessions covering the key, and most current issues in contract manufacturing for biopharmaceuticals.
- Our bio stream will allow professionals who outsource both clinical and commercial manufacturing for biopharmaceuticals and biologics to discuss the most specific challenges within the bio-outsourcing area.
Feedback from our previous event
An excellent process review of external manufacturing.Bruno Chetail, Merck Serono
I like the mix of virtual big pharma, CMOs & even equipment vendors. It was valuable, we will attend next year.Jeff Milligan, Hollisterstier Labs
Excellent post presentation group discussions.Ian Anderson, Norgine
Once again a great event. The place to hear about & discuss the relationship between pharma & CMOsRoss Errington, 3M Drug Delivery Systems
Sponsors & Exhibitors
Media Patners
